Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 521
Clinical Impacts of Structured Robotic Gait Training Programs
for
Neuromotor Impairments, Walking Impairment
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 0+
Code: NCT07405450
Recruiting
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Location: Calgary, Vancouver, Aurora CO, San Diego CA, Chicago IL,
Sponsor: Boston Children's Hospital
Sex: All
Age: 0+
Code: NCT04507997
Recruiting
Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children
for
Asthma
Location: Calgary, Edmonton
Sponsor: Janielee Williamson
Sex: All
Age: 1 - 5
Code: NCT01008761
Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Calgary, Seattle WA, Portland OR, Salt Lake City UT,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Calgary, Edmonton, Vancouver, Aurora CO, Oakland CA,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT05995353
Phase 3, Recruiting
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor